Repligen Corp (NAS:RGEN)
$ 166.895 -4.885 (-2.84%) Market Cap: 9.33 Bil Enterprise Value: 9.56 Bil PE Ratio: 667.58 PB Ratio: 4.73 GF Score: 93/100

Repligen Corp at William Blair Growth Stock Conference (Virtual) Transcript

Jun 01, 2021 / 05:40PM GMT
Release Date Price: $172.75 (-5.40%)
John Charles Kreger
William Blair & Company L.L.C., Research Division - Partner & Co-Group Head of Healthcare Technology and Services

All right. Good afternoon, everyone. Welcome to our next session at the William Blair Growth Stock Conference that is Repligen. Thank you all for joining us. I'm John Kreger, the analyst that covers Repligen at William Blair. You can see our website at williamblair.com for any conflicts of interest or other disclosures. As we've been doing all morning, this is going to be a fireside chat. The speaker is Tony Hunt, the CEO. So we've got 30 minutes with Tony. Tony, thank you again for your time.

Anthony J. Hunt
Repligen Corporation - CEO, President & Director

Yes. Thank you, John.

John Charles Kreger
William Blair & Company L.L.C., Research Division - Partner & Co-Group Head of Healthcare Technology and Services

Wonderful. And again, for those of you listening, I'll be delivering the questions to Tony. But if any of you have questions, feel free to submit them to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot